These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

967 related articles for article (PubMed ID: 29505836)

  • 61. HIF-1α-activated TM4SF1-AS1 promotes the proliferation, migration, and invasion of hepatocellular carcinoma cells by enhancing TM4SF1 expression.
    Zeng Z; Shi Z; Liu Y; Zhao J; Lu Q; Guo J; Liu X; Huang D; Xu Q
    Biochem Biophys Res Commun; 2021 Aug; 566():80-86. PubMed ID: 34118595
    [TBL] [Abstract][Full Text] [Related]  

  • 62. MiR-148b suppresses cell proliferation and invasion in hepatocellular carcinoma by targeting WNT1/β-catenin pathway.
    Zhang JG; Shi Y; Hong DF; Song M; Huang D; Wang CY; Zhao G
    Sci Rep; 2015 Jan; 5():8087. PubMed ID: 25627001
    [TBL] [Abstract][Full Text] [Related]  

  • 63. MicroRNA-145 and MicroRNA-133a Inhibited Proliferation, Migration, and Invasion, While Promoted Apoptosis in Hepatocellular Carcinoma Cells Via Targeting FSCN1.
    Wang G; Zhu S; Gu Y; Chen Q; Liu X; Fu H
    Dig Dis Sci; 2015 Oct; 60(10):3044-52. PubMed ID: 26173501
    [TBL] [Abstract][Full Text] [Related]  

  • 64. MicroRNA-133a functions as a tumor suppressor by targeting IGF-1R in hepatocellular carcinoma.
    Zhang W; Liu K; Liu S; Ji B; Wang Y; Liu Y
    Tumour Biol; 2015 Dec; 36(12):9779-88. PubMed ID: 26156803
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
    Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
    BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Overexpression of circ_0021093 circular RNA forecasts an unfavorable prognosis and facilitates cell progression by targeting the miR-766-3p/MTA3 pathway in hepatocellular carcinoma.
    Liu L; Qi X; Gui Y; Huo H; Yang X; Yang L
    Gene; 2019 Sep; 714():143992. PubMed ID: 31330234
    [TBL] [Abstract][Full Text] [Related]  

  • 67. MiR-122 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting Snail1 and Snail2 and suppressing WNT/β-cadherin signaling pathway.
    Jin Y; Wang J; Han J; Luo D; Sun Z
    Exp Cell Res; 2017 Nov; 360(2):210-217. PubMed ID: 28890291
    [TBL] [Abstract][Full Text] [Related]  

  • 68. MicroRNA-133b inhibits hepatocellular carcinoma cell progression by targeting Sirt1.
    Tian Z; Jiang H; Liu Y; Huang Y; Xiong X; Wu H; Dai X
    Exp Cell Res; 2016 May; 343(2):135-147. PubMed ID: 27090017
    [TBL] [Abstract][Full Text] [Related]  

  • 69. MicroRNA-639 is Down-Regulated in Hepatocellular Carcinoma Tumor Tissue and Inhibits Proliferation and Migration of Human Hepatocellular Carcinoma Cells Through the KAT7/Wnt/β-Catenin Pathway.
    Bai Z; Xia X; Lu J
    Med Sci Monit; 2020 Jan; 26():e919241. PubMed ID: 31955177
    [TBL] [Abstract][Full Text] [Related]  

  • 70. MicroRNA-6809-5p mediates luteolin-induced anticancer effects against hepatoma by targeting flotillin 1.
    Yang PW; Lu ZY; Pan Q; Chen TT; Feng XJ; Wang SM; Pan YC; Zhu MH; Zhang SH
    Phytomedicine; 2019 Apr; 57():18-29. PubMed ID: 30668319
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Methylation-mediated repression of microRNA-129-2 suppresses cell aggressiveness by inhibiting high mobility group box 1 in human hepatocellular carcinoma.
    Liu Z; Dou C; Yao B; Xu M; Ding L; Wang Y; Jia Y; Li Q; Zhang H; Tu K; Song T; Liu Q
    Oncotarget; 2016 Jun; 7(24):36909-36923. PubMed ID: 27191994
    [TBL] [Abstract][Full Text] [Related]  

  • 72. MicroRNA‑577 inhibits the migration and invasion of hepatocellular carcinoma cells by targeting homeobox A1.
    Han S; Liu Z; Wang Y; Wang L; Yao B; Guo C; Song T; Tu K; Liu Q
    Oncol Rep; 2018 Jun; 39(6):2987-2995. PubMed ID: 29693150
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Down-regulated miR-28-5p in human hepatocellular carcinoma correlated with tumor proliferation and migration by targeting insulin-like growth factor-1 (IGF-1).
    Shi X; Teng F
    Mol Cell Biochem; 2015 Oct; 408(1-2):283-93. PubMed ID: 26160280
    [TBL] [Abstract][Full Text] [Related]  

  • 74. miR-539 inhibits FSCN1 expression and suppresses hepatocellular carcinoma migration and invasion.
    Liu Y; Hong W; Zhou C; Jiang Z; Wang G; Wei G; Li X
    Oncol Rep; 2017 May; 37(5):2593-2602. PubMed ID: 28393215
    [TBL] [Abstract][Full Text] [Related]  

  • 75. MicroRNA-139 inhibits hepatocellular carcinoma cell growth through down-regulating karyopherin alpha 2.
    Zan Y; Wang B; Liang L; Deng Y; Tian T; Dai Z; Dong L
    J Exp Clin Cancer Res; 2019 May; 38(1):182. PubMed ID: 31046781
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.
    Cao Y; Chen J; Wang D; Peng H; Tan X; Xiong D; Huang A; Tang H
    Oncotarget; 2015 Nov; 6(35):38093-106. PubMed ID: 26497554
    [TBL] [Abstract][Full Text] [Related]  

  • 77. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo.
    He XX; Chang Y; Meng FY; Wang MY; Xie QH; Tang F; Li PY; Song YH; Lin JS
    Oncogene; 2012 Jul; 31(28):3357-69. PubMed ID: 22056881
    [TBL] [Abstract][Full Text] [Related]  

  • 78. miR-34c-3p inhibits cell proliferation, migration and invasion of hepatocellular carcinoma by targeting MARCKS.
    Song J; Wang Q; Luo Y; Yuan P; Tang C; Hui Y; Wang Z
    Int J Clin Exp Pathol; 2015; 8(10):12728-37. PubMed ID: 26722462
    [TBL] [Abstract][Full Text] [Related]  

  • 79. MicroRNA-155 promotes tumor growth of human hepatocellular carcinoma by targeting ARID2.
    Zhang L; Wang W; Li X; He S; Yao J; Wang X; Zhang D; Sun X
    Int J Oncol; 2016 Jun; 48(6):2425-34. PubMed ID: 27035278
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Androgen receptor (AR)/miR-520f-3p/SOX9 signaling is involved in altering hepatocellular carcinoma (HCC) cell sensitivity to the Sorafenib therapy under hypoxia via increasing cancer stem cells phenotype.
    Xiao Y; Sun Y; Liu G; Zhao J; Gao Y; Yeh S; Gong L; Chang C
    Cancer Lett; 2019 Mar; 444():175-187. PubMed ID: 30448543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 49.